Thomas Prock

Marks & Clerk LLP

Thomas is a Patent Attorney who advises clients in the high tech field, in particular, in the electronics sector on internet related subject matter and computer-implemented inventions. He is very active in protecting inventions in both the Cleantech and medical device fields.
He has worked on patent applications relating to non-volatile semiconductor storage devices, data processing and exchange, mobile telecommunications, smart grid related inventions, waste reduction and medical imaging, to name a few.
Thomas graduated with a Diploma in Biomedical Engineering from the University of Applied Science in Ulm (Germany) and went on to obtain his PhD from the Institute of Cancer Research, where he investigated the interaction between radio frequency electromagnetic fields and conducting tissue, with particular emphasis on its application to the design of phased array resonators.
Having qualified as a Chartered (UK) and European Patent Attorney, in 2014 Thomas became one of the few professionals to also qualify as a Patentanwalt (German Patent Attorney).

dont miss

Is the IP in your business investment ready?

Intellectual Property (IP) is in every part of your business – from product development to manufacturing. The IP audit and the IP strategy are two key management tools that can support your business plans ensuring you are prepared for investors when they are considering investing in your business.
An IP audit helps you identify what assets you have, their protection status, where you are using them along with any legal issues. An IP strategy considers your commercial goals detailing how you are managing your IP assets and handling any threats to it, such as infringements or competitors.
In this session we will use practical, day to day examples helping you identify red flags in your audit and giving ideas on how to create a robust strategy. These will help you discover new ways to capitalise on them and make better strategic business decisions when it comes to leveraging new opportunities.

EVEN MORE SEMINARS

  • Heather Campbell: Speaking at the European Neurological Convention

    Heather Campbell
    Guys & St Thomas’ NHS Foundation trust

    Navigating pathways for “invisible patients” in South East London

  • Andrew Fahey: Speaking at the European Neurological Convention

    Andrew Fahey
    Brookson Direct

    The Impact of IR35 on the NHS

  • Amy Bean: Speaking at the European Neurological Convention

    Amy Bean
    Saebo UK

    Introducing the SaeboVR – Virtual ADL Rehab System

  • Xavier Golay, Ph.D.: Speaking at the European Neurological Convention

    Xavier Golay, Ph.D.
    Professor of MR Neurophysics and Translational Neuroscience

    Image-based biomarkers of disease progression in dementia: current and future prospects

  • Prof Xavier Golay: Speaking at the European Neurological Convention

    Prof Xavier Golay
    Gold Standard Phantoms Limited

    Reference standards for establishment of quantitative imaging biomarkers in neurology